• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节性硬化症复杂基因的多种作用。

Multiple roles of the tuberous sclerosis complex genes.

作者信息

Yeung Raymond S

机构信息

Department of Surgery, University of Washington, Seattle, Washington, USA.

出版信息

Genes Chromosomes Cancer. 2003 Dec;38(4):368-75. doi: 10.1002/gcc.10256.

DOI:10.1002/gcc.10256
PMID:14566857
Abstract

Soon after proposing the "two-hit" hypothesis for tumorigenesis, Knudson pursued further experimental validation of the concept by using a rat model of dominantly inherited renal tumor. Today, the Eker rat is one of the best characterized models of tuberous sclerosis complex (TSC) and has been used extensively for study of the function of the TSC2 tumor suppressor gene. Along with TSC1, these two genes behave as expected for tumor suppressor genes with evidence for loss of heterozygosity in tumors and suppression of growth when expressed in proliferating cells. Despite much experimental work, the mechanisms of these genes have remained elusive until recently. This review summarizes some of the current concepts in our understanding of the biological and biochemical function of the TSC genes.

摘要

在提出肿瘤发生的“两次打击”假说后不久,克努森通过使用显性遗传肾肿瘤的大鼠模型,对这一概念进行了进一步的实验验证。如今,埃克大鼠是结节性硬化症复合体(TSC)特征最明确的模型之一,并已广泛用于研究TSC2肿瘤抑制基因的功能。与TSC1一起,这两个基因表现出肿瘤抑制基因所预期的特性,有证据表明肿瘤中杂合性缺失,且在增殖细胞中表达时可抑制生长。尽管进行了大量实验工作,但直到最近,这些基因的作用机制仍不清楚。本综述总结了目前我们对TSC基因生物学和生化功能理解中的一些概念。

相似文献

1
Multiple roles of the tuberous sclerosis complex genes.结节性硬化症复杂基因的多种作用。
Genes Chromosomes Cancer. 2003 Dec;38(4):368-75. doi: 10.1002/gcc.10256.
2
Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.结节性硬化症(TSC)基因产物的杂合性导致TSC2+/-细胞中星形胶质细胞数量增加和p27-Kip1表达降低。
Oncogene. 2002 Jun 6;21(25):4050-9. doi: 10.1038/sj.onc.1205435.
3
Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.日本肺淋巴管平滑肌瘤病患者TSC1和TSC2基因的突变分析
J Hum Genet. 2002;47(1):20-8. doi: 10.1007/s10038-002-8651-8.
4
Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells.通过在埃克大鼠肾癌细胞中替换Tsc2基因来抑制肿瘤表型。
Biochem Biophys Res Commun. 1996 Feb 6;219(1):70-5. doi: 10.1006/bbrc.1996.0183.
5
The cell cycle and tuberous sclerosis.细胞周期与结节性硬化症
Prog Cell Cycle Res. 2003;5:43-8.
6
Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model.艾克大鼠模型的结节性硬化症(Tsc2)基因易感性产物中存在有效的转录激活结构域。
Cancer Res. 1996 Feb 1;56(3):429-33.
7
Absence of allelic loss in cytomegalic neurons of cortical tuber in the Eker rat model of tuberous sclerosis.结节性硬化症的Eker大鼠模型中,皮质结节巨细胞神经元不存在等位基因缺失。
Acta Neuropathol. 2004 Jan;107(1):47-52. doi: 10.1007/s00401-003-0778-y. Epub 2003 Oct 18.
8
Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2.患有结节性硬化症复合体的患者中,骶尾部脊索瘤显示TSC1或TSC2的体细胞缺失。
Genes Chromosomes Cancer. 2004 Sep;41(1):80-5. doi: 10.1002/gcc.20052.
9
Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex.悼念阿尔弗雷德·G·克努森博士:双打击假说、肿瘤抑制基因与结节性硬化症复合体
Cancer Sci. 2017 Jan;108(1):5-11. doi: 10.1111/cas.13116. Epub 2017 Jan 23.
10
Identification of cDNAs induced by the tumor suppressor Tsc2 gene using a conditional expression system in Tsc2 mutant (Eker) rat renal carcinoma cells.在Tsc2突变(Eker)大鼠肾癌细胞中使用条件表达系统鉴定由肿瘤抑制基因Tsc2诱导的cDNA。
Biochem Biophys Res Commun. 1998 Jun 29;247(3):728-33. doi: 10.1006/bbrc.1998.8853.

引用本文的文献

1
An Update on the Ophthalmologic Features in the Phakomatoses.色素沉着性视网膜炎的眼科特征最新进展。
J Ophthalmol. 2016;2016:3043026. doi: 10.1155/2016/3043026. Epub 2016 Jul 17.
2
SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis.Src 激酶是淋巴管平滑肌瘤病的一个新的治疗靶点。
Cancer Res. 2014 Apr 1;74(7):1996-2005. doi: 10.1158/0008-5472.CAN-13-1256.
3
Fibrous papule of the face, similar to tuberous sclerosis complex-associated angiofibroma, shows activation of the mammalian target of rapamycin pathway: evidence for a novel therapeutic strategy?
面部纤维性丘疹,类似于结节性硬化症相关的血管纤维瘤,显示出雷帕霉素哺乳动物靶点通路的激活:一种新治疗策略的证据?
PLoS One. 2014 Feb 18;9(2):e89467. doi: 10.1371/journal.pone.0089467. eCollection 2014.
4
Crossing paths in Human Renal Cell Carcinoma (hRCC).人类肾细胞癌(hRCC)中的交叉路径
Int J Mol Sci. 2012 Oct 5;13(10):12710-33. doi: 10.3390/ijms131012710.
5
Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN.抑癌基因 FLCN 对线粒体氧化代谢的调控。
J Natl Cancer Inst. 2012 Nov 21;104(22):1750-64. doi: 10.1093/jnci/djs418. Epub 2012 Nov 12.
6
ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.喹喔啉硫醚诱导的结节性硬化症肾细胞癌中 ERK 与 4EBP1 相互作用激活 cyclin D1 的翻译。
Toxicol Sci. 2011 Nov;124(1):75-87. doi: 10.1093/toxsci/kfr203. Epub 2011 Aug 2.
7
mTORC2 is required for proliferation and survival of TSC2-null cells.mTORC2 对于 TSC2 缺失细胞的增殖和存活是必需的。
Mol Cell Biol. 2011 Jun;31(12):2484-98. doi: 10.1128/MCB.01061-10. Epub 2011 Apr 11.
8
PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects.错构瘤综合征中的PI3K/mTORC1激活:治疗前景
Cell Cycle. 2009 Feb 1;8(3):403-13. doi: 10.4161/cc.8.3.7555. Epub 2009 Feb 6.
9
Irradiation exacerbates cortical cytopathology in the Eker rat model of tuberous sclerosis complex, but does not induce hyperexcitability.在结节性硬化症的埃克大鼠模型中,辐射会加剧皮质细胞病理学变化,但不会诱发过度兴奋。
Epilepsy Res. 2007 Jan;73(1):53-64. doi: 10.1016/j.eplepsyres.2006.08.003. Epub 2006 Sep 29.
10
A defect in protein farnesylation suppresses a loss of Schizosaccharomyces pombe tsc2+, a homolog of the human gene predisposing to tuberous sclerosis complex.蛋白质法尼基化缺陷抑制了粟酒裂殖酵母tsc2 +的缺失,tsc2 +是人类基因的同源物,该人类基因易导致结节性硬化症复合体。
Genetics. 2006 Jun;173(2):569-78. doi: 10.1534/genetics.106.056895. Epub 2006 Apr 19.